Back to search
Premature With Dysplasia Bronchopulmonary
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Premature With Dysplasia Bronchopulmonary trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Premature With Dysplasia Bronchopulmonary trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this clinical trial is to learn if transpyloric tube feeding (feeding directly into the small intestine) versus gastric tube feeding tolerably and e…
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children…
The purpose of the study is to learn how safe montelukast may be in premature infants at significant risk for Bronchopulmonary Dysplasia (BPD) and to determine…
Around 50% of infants born extremely preterm develop a chronic lung disease known as bronchopulmonary dysplasia of which some infants will also develop pulmonar…
The goal of this study is to learn how a pregnant person's body processes caffeine and how much caffeine crosses the placenta to the baby. A small dose of caffe…
The researchers have worked to create consensus recommendations among national efforts to help with the transition and coordination of care for preterm infants…
The goal of this clinical trial is to learn if budesonide works to prevent bronchopulmonary dysplasia in newborn less than 32 weeks gestational age or birth wei…
Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data from the First Three Postnatal Weeks with Large Language Models: A Retrosp…